TECH & INNOVATIONIn the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.
Results from the trials combining Incyte’s epacadostat and Merck's Keytruda were revealed. Incyte’s epacadostat was described to be an oral inhibitor of the IDO1 enzyme that stops cancer cells.
Space Travellers will be facing a tough challenge when facing situations that require emergency medical procedures in the deep realm of space. A multitasking training is suggested to secure the safety of fellow space crew in the field of emergency medical applications.
American Society of Clinical Oncology (ASCO) presented the research of the effectiveness of Zytiga to boost the survival rate for severe prostate cancers.
Summer health risks is fun and exciting. The awareness of the health risks like spider bites and bee stings that go with the summer fun will help the most of enjoying the rest of the season.
A study found out that breastfeeding after undergoing cesarean delivery eases chronic pain. The latest guidelines from the World Health Organization (WHO) is said to be that babies should be breastfed for the first 6 months of their life.